TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $19,416,000 | -55.3% | 2,001,686 | -50.5% | 2.36% | -50.0% |
| Q1 2021 | $43,390,000 | -27.0% | 4,040,000 | 0.0% | 4.71% | -46.1% |
| Q4 2020 | $59,428,000 | -42.0% | 4,040,000 | -43.9% | 8.74% | -56.4% |
| Q3 2020 | $102,377,000 | +86.4% | 7,204,577 | +6.1% | 20.03% | +52.3% |
| Q2 2020 | $54,931,000 | +100.2% | 6,790,000 | 0.0% | 13.15% | +77.0% |
| Q1 2020 | $27,432,000 | – | 6,790,000 | – | 7.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |